Featured News

SIDP co-sponsors two sessions at IDWeek October 2-6, 2019 in Washington DC.

The first session is entitled "Experience and Challenges with Vancomycin Monitoring by AUC" with speakers  William L. Musick, PharmD and Jennifer Le, PharmD, MAS, moderated by Jason Pogue, PharmD, BCPS, BCIDP and Vincent Tam, PharmD.

The second session is entitled "Optimizing PK/PD of New Antibiotics Against MDR Organisms" with speakers Marc H. Sheetz, PharmD, MSc, Kamilia Abdelraouf, PhD, Alexander Lepak, MD, moderated by Vincent Tam, PharmD, and Elizabeth Hirsch, PharmD.

SIDP and the Infectious Diseases PRN co-sponsor a focus session entitled "Power Gaps in Stewardship: Decision Making for Diagnostics and Transitions of Care" with speakers John A. Bosso, PharmD, FCCP, FIDP, Nick Mercuro, PharmD, and Stephanie Harding, PharmD, BCPS-AQ ID with moderator Whitney J. Nesbitt, PharmD at the ACCP Annual Meeting October 26-29, 2019 in New York, NY.

Learn More about this session and how to attend the ACCP Annual Meeting

In August, SIDP partnered with Pharmacy Times through their Strategic Alliance Program. Though this partnership, SIDP will extend its mission to a broader pharmacist audience and expand its educational offerings. Additionally, an SIDP member will serve on the Pharmacy Times advisory editorial board.

Learn more about this partnership

SIDP signed on to a letter of support, along with the  American Academy of Allergy, Asthma & Immunology and 14 other organizations, encouraging the FDA to.expedite the approval of products that can be used for penicillin skin testing.

The letter can be accessed here

The Strategies to Address Antimicrobial Resistance (STAAR) Act was reintroduced by Senator Sherrod Brown (D-OH). Additional information on the bill will posted when it is available at www.congress.gov . Similar to the DISARM Act, SIDP has signed on to a letter of support with other infectious diseases organizations for both bills.

 

CMS Published their Finalized FY2020 Inpatient Prospective Payment System (IPPS) Ruling on August 2^nd.  Although there were no new incentives for antimicrobial stewardship, they did increase the new technology add-on payment (NTAP) for certain antimicrobials from 50% to 75%. In addition, there is a new ID rapid diagnostic test that met the criteria for an NTAP payment. CMS is also finalizing an alternative NTAP pathway for antimicrobials with a Qualified Infectious Diseases (QIDP) designation. The pre-publication version is available here but a concise summary is available here.

However, despite the lack of mention of ASP in the IPPS ruling, CMS did announce in June that the timeline has been extended by 1 year for publication of the long-awaited Conditions of Participation requirements for antibiotic stewardship programs in acute care and critical access hospitals including critical access hospitals. This deadline has been extended given extensive feedback received by individuals and professional societies including SIDP. It is now anticipated the final rule will be published on or before June of 2020. Read the full update at the link here

The joint commission released Medication Management Standard 09.01.03 on June 20^, 2019 that requires antibiotic stewardship in ambulatory health care. These standards require Joint Commission-accredited ambulatory health care organizations that routinely prescribe antibiotics to identify a stewardship leader, develop annual goals to improve prescribing, develop local evidence-based guidelines, provide educational resources to all staff, and collect and report data related to stewardship goals. This standard goes into effect January 1, 2020.

Thanks for a great webinar! We had 127 registered and 80 attendees.

The recorded webinar and slides can also be viewed on the LearningCE.

Merging Microbiology and Stewardship: Making the Most of 2019 CLSI Updates on Antimicrobial Susceptibility Testing in your Stewardship Activities,  A Home Study CE Webinar for Pharmacists and Laboratory Professionals 

This annual webcast provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast includes recent CLSI antimicrobial susceptibility testing updates for gram positive and gram negative bacteria. Ways to incorporate these changes in your antimicrobial stewardship efforts are also discussed.

Cost: $35  (fee waived for SIDP Members with code in email)

To participate in this activity and for full information, see:
http://www.proce.com/activities/activity_detail?id=891

The Society of Infectious Diseases Pharmacists (SIDP) is pleased to solicit nominations for Fellowship in SIDP (FIDP). The Fellowship distinction was developed to recognize outstanding SIDP members who have made a significant and sustained contribution to the area of infectious diseases and the mission of SIDP. Successful applicants for Fellowship in SIDP demonstrate a commitment to promoting the appropriate use of antimicrobials for the prevention and management of infectious diseases through leadership and collaboration in infectious diseases practice, education, research, and advocacy.

Please consider nominating a colleague for this award, to be given at the Annual Meeting in Washington, DC on October 1, 2019.  Further information regarding the nomination and application process is provided below.

Minimum Eligibility Criteria

Nominees for FIDP must meet all of the following criteria:

1) Be a current active member of SIDP

2) Have been in practice in the field of infectious diseases for at least 10 years since receipt of terminal training (not including residency or fellowship)

3) Have made sustained contributions to SIDP as detailed in the evaluation criteria

4) Be present in Washington, DC on October 1, 2019 to be recognized

*Note: Current SIDP board members or Recognition Awards Committee members are ineligible for nomination

In order to be considered for distinction, an initial nomination in the form of a letter from an active member of SIDP is required.  The nomination letter should be submitted via email to the Chair of the Recognition Awards Committee, Molly Steed (msteed@ku.edu). The nomination letter should outline how the nominee fulfills the eligibility criteria, including a brief description of the nominee’s sustained contributions to SIDP and excellence in the field of infectious diseases through practice, education, scholarship, etc. The nomination letter should also include the nominee’s current email and phone number. Nominations will be accepted annually. The deadline for nominations this cycle is Wednesday, May 15, 2019.

Nominees fulfilling minimum eligibility requirements will be sent a link to an on-line application form. The deadline for full applications is Wednesday, July 10, 2019.  Awardees will be notified no later than Friday, August 16, 2019. More details on the application process including a copy of the application and the scoring rubric can be found here:  http://sidp.org/FIDP.

FIDP designations will be awarded at the SIDP Annual Meeting on October 1, 2019.

Please consider your deserving colleagues for this award! 

Sincerely,

The SIDP Recognition Awards Committee